Young, potent allogeneic cells harvested ethically from donated cord tissue.
Cells harvested from umbilical-cord blood or tissue (Wharton's jelly, amnion) immediately after delivery—a one-time source of stem and immune cells. They're young, expand vigorously in culture, and are being studied for immune disorders, inflammatory conditions, and neurological injury. Clinics favour cord cells because they're non-invasive to collect and less immunogenic than adult cells. When evaluating clinics, ask about viability post-thaw (cord cells stored for years may have degraded) and whether the clinic tests for infectious agents comprehensively. Also clarify whether they're using fresh cord cells or centuries-old cryopreserved samples.
StemCellAtlas is your guide to stem-cell therapy: what the evidence shows, which conditions are treated, and the real all-in cost by country — typically €3,000–8,000 with our partner Stem Plus (Sofia), Europe's lowest-cost EU destination, versus $15,000–35,000 in the US.
Get an honest assessment